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Cantharidin, a natural toxicant of blister beetles, is a strong Inhibitor of protein phosphatases types l(PPI) and 2A (PPZA). Like okadaic acid, 
cantharidin inhibits the activity of the purified catalytic subunit of PPZA (IC,, = 0.16 PM) at a lower concentration than that of PPl (IC,,, = 1.7 
,uM) and only inhibits the activity of protein phosphatase type 2B (PP2B) at high concentrations. Dose+mhibition studies conducted with whole 
cell homogenates indicate that cantharidin also inhibits the native forms of these enzymes. Thus, cantharidin. which 1s economical and readily 
available, may be useful as an additional probe for studying the functions of serinelthreonine protein phosphatases. 
Canthandin: Serinejthreonine. Protein: Phosphatase: Inhibitor: Dephosphorylation: Toxin 
1. INTRODUCTION 
Mylabris, the dried body of the Chinese blister beetle 
(Mylabris phalerata or M. cichorii), can be traced back 
more than 2,000 years as a traditional medicine in 
China and is still used as a folk medicine in Asia today 
[l]. The active constituent of mylabris, cantharidin (exo, 
exo-2,3-dimethyl-7-oxabicyclo[2.2.l]heptane-2.3-dicar- 
boxylic acid anhydride) (Fig. l), is produced by as many 
as 1500 different species of blister beetles, with the 
Spanish fly Cantharis vesicatoria probably being the 
best known source [l-3]. Cantharidin also has a history 
of medical usage in Europe where it was first isolated 
in the early 1800’s as the active principle of a blister 
beetle extract [3]. Although occasionally utilized as a 
topical vesicant for the removal of warts [4], cantharidin 
was considered as obsolete and too toxic for use as an 
internal medicine by the early 1900’s. Nonetheless, folk- 
lore surrounding the purported properties of ‘Spanish 
fly’ as an aphrodisiac and abortifacient continues to 
result in human poisonings today, with 26-50 mg esti- 
mated as a lethal dose for humans [5]. Livestock toxico- 
sis due to the consumption of feed containing blister 
beetles also continues to present a problem for ranchers 
F51. 
The toxic properties of cantharidin are well charac- 
terized. Dermal contact produces blisters characterized 
by a distinctive vesiculobullous eruption [7,8]. Oral in- 
gestion leads to severe irritation and ulceration of the 
gastrointestinal and urinary tract epithelial linings [3,9], 
and intraperitineal injection causes severe congestion 
and edema of the liver, with a LD,, = 1 mg/kg [lO,ll]. 
The cellular mechanisms underlying the toxicity of 
cantharidin have been under investigation for several 
years. Early studies indicated that cantharidin inter- 
fered with mitochondrial respiration [ 12,131 or induced 
the activation of an acantholytic factor [S]. Cantharidin 
was then shown to bind with high affinity to a specific 
and saturable binding site in a cytosolic fraction pro- 
duced from mouse liver [14.15]. This high-affinity can- 
tharidin binding site was subsequently identified in sev- 
eral other tissues including: heart. kidney, lung, pan- 
creas, skin. spleen, brain, blood and stomach [15]. Re- 
cently, Li and Casida [ 161 purified the cantharidin-bind- 
ing protein (CBP) to homogeneity, identifying it as pro- 
tein phosphatase type 2A (i.e. the amino acid sequences 
of seven peptides from CBP were identical with deduced 
amino acid sequences for PP2A,. CPB had phosphory- 
lase a phosphatase activity which was inhibited by both 
okadaic acid and cantharidic acid, and okadaic acid 
inhibited the binding of [‘Hlcantharidin to CBP). 
The present report characterizes the inhibitory activ- 
ity of cantharidin on the activity of the purified catalytic 
subunits of serine/threonine protein phosphatases types 
1 (PPl ), 2A (PP2A) and 2B (PP2B) and in whole cell 
homogenates of PC1 2 cells. These studies indicate that, 
like okadaic acid. cantharidin is a strong inhibitor of 
PPI and PP2A and a weak inhibitor of PP2B. 
2. MATERIALS AND METHODS 
Phosphorylase kmase (EC 2.7.1.38) and protein kinase A (3’.5’- 
cyclic AMP-dependent protein k1nase) from rabbit muscle. histone 
(type 2AS). PP2B (calcmeunn) and calmodulin (phosphodiesterase 
3’:5’-cyclic nucleotide activator) from bovine brain. andp-nitrophenyl 
phosphate (PNPP) were obtained from Sigma Company and utilized 
without further punfication. Cantharidin was purchased from Sigma 
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chetmcal company and exhIbIted >98% purity by CC/MS analysis. 
Okadalc acid was generously provided by Dr. R. Dickey. 
2.2. Detrrrmnatmn ojprotem phosphatase uc’trvrt?, 
The catalytic subunIt of PPI and PPZA were purified to apparent 
homogeneity. demonstrating a single band upon SDS-PAGE and sil- 
ver stainmg. as described by Honkanen et al. [I 7-l 91. Inhibition assays 
conducted with purified PPI and PP2A contained 125 pM PPI or 25 
pM PP2A having phosphohistone phosphatase activity of 265 + 15 
and 1250 + 62 nmol/mm/mg of protein, respectively. Phosphohistone, 
specific activity 4.5 x 1 O6 dpmlnmol of incorporated phosphate, was 
prepared by the phosphorylation of lustone (type 2AS from Sigma) 
with CAMP-dependent protein kinase (protein kinase A) m the pres- 
ence of [y-“P]ATP (150 ,uM ATP) as described m detail previously 
[18]. Protein phosphatase activity against phosphohistone was deter- 
mmed by the liberation of “P usmg either the purified catalytic sub- 
units of the mchcated protein phosphatases (Figs. 2 and 3) or a dilute 
whole cell homogenate of PC12 cells (Fig. 4). The dephosphorylation 
of substrate was c 10% of the total, and reactions were linear with 
respect to enzyme concentration and time [I 81. “P-phosphate liberated 
by the enzymes was extracted as a phosphomolybdate complex and 
measured according to the methods of Kilhlea et al [20]. Inhibition 
of phosphatase activity was determined bq the addition of toxins to 
the assay mixture IO mm before Initiation of the reaction with the 
addition of substrate [IS]. Okadaic acid and cantharidin were &s- 
solved m dlmethyl formamide (DMF), which was added in equal 
amounts to controls. PP2B activity was measured using PNPP as a 
substrate m the presence of calmodulin and Ca”. as described previ- 
ously [18]. 
Previous experiments have indicated that for compounds that be- 
have as ‘tightly binding inhibitors’ the determination of K, by fitting 
dose-mhlbitlon relatlonshlps to the theoretical function by an ordi- 
nary nonlinear least-squares methods does not provide reliable confi- 
dence hmits [21]. However, as demonstrated for okadaic acid, the 
dose-inhibitlon of ‘tightly bmdmg Inhibitors’ is well described by the 
followmg equation, derived with steady-state assumptions, 
s = [(I?,-1,-K,) + d(E,-1,-K,)’ + 4 E;KJ /2E, (1) 
where s stands for the fractional activity v,/v,, K, 1s the dissociation 
constant, and E, and Z, are the total concentration of the enzyme and 
inhibitor. respectlvelq [21] For the set of observations (1,. .u) and 
(I’,. ~‘1. rearrangement of equation 1 gives. 
I( 1 -u)E, + ( 1 -.Y)K, = YI, and I’( 1 -I’)/?, + ( 1 -.C)K, = ?.I,’ 
K, values were estimated as means of the solutions obtained by solving 
the simultaneous equations for all possible sets of observations [?I]. 
This procedure is the direct-linear plot method for estimation of en- 
zyme-kinetic constants [22] as modified by Takai et al. [21]. Theoret- 
lcal hmlts of this application have been discussed previously [21,23]. 
3. RESULTS 
The dephosphorylation of phosphohistone by the pu- 
rified catalytic subunits of both PPl and PPZA is inhib- 
ited by cantharidin, which also inhibits the activity 
of PP2B at higher concentrations (Fig. 2, Table I). 
Cantharidin inhibits the activity of PPl and PP2A 
in a dose-dependent manner, inhibiting PP2A (IC,,, = 
0.16 5 0.06 PM; mean +_ S.D., n = 4) at a 10.6- fold 
lower concentration than PPl(IC,, = 1.70 2 0.5 PM; 
mean + S.D.. rz = 4); PPZB is inhibited by cantharidin 
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Fig. 1 Structure of cantharidin. 
at a >500-fold higher concentration than that which 
inhibits PPl (Fig. 2). Under identical assay conditions 
okadaic acid inhibits the activity of PP2A (IC,,-0.04 nM) 
at a > 1 ,OOO-fold lower concentration than cantharidin 
(Fig. 3). 
To determine whether cantharidin inhibits the activ- 
ity of the native forms of PPl and PPZA at a compara- 
ble concentration to that observed with the respective 
purified catalytic subunits. we examined the effects of 
cantharidin in whole cell homogenates of PC12 cells. 
Fig. 4 shows the inhibitory dose-response of can- 
tharidin and okadaic acid in a dilute whole cell homoge- 
nate of PC12 cells (60 ,ug protein/ml). Both toxins inhib- 
ited the divalent cation-independent protein phosphat- 
ase activity (predominately PPl and PP2A) in the 
whole-cell homogenate, with 0.1 ,uM okadaic acid and 
100pM cantharidin causing 100% inhibition. Nonlinear 
regression analyses of the dose-inhibition curves ob- 
tained with both okadaic acid and cantharidin indicate 
that the divalent cation-independent phosphatase activ- 
ity contained in the PC12 cell homogenate best fits a 
-. 
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Fig. 2. Inhibition of protem phosphatases by cantharidm. The cata- 
lytic subunits of PPI and PP2A were assayed using “P-labeled lustone 
as a substrate and PPZB using PNPP as a substrate as described in 
Section 2. The data is expressed as % of control, with control activity 
against phospholustone bemg 265 + IS and I.250 + 62 nmol/min/mg 
protein for PPI and PP2A. respectively. Cantharidm was mlxed with 
the enzymes for IO min at 23°C prior to the mitlation of the reactlon 
with the addition of substrate. The data represents the mean ? S.D. 
of all data obtained from at least 4 separate experiments employing 
two different preparatlona of each enzyme tested. 
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Fig. 3. Comparison of the inhibttory effect of okadaic acid and can- 
tharidin on the activity of the purified catalytic subunit of PPZA from 
muscle. Assays were conducted as described in Figure 2 using 
phosphohistone as a substrate and with enzymes having comparable 
nntial activity. Both toxms were mixed with the enzyme 10 min at 23°C 
prior to the addition of substrate. Each point represents the 
mean 2 SD. (n = 4). 
two-site model, which is consistent with that predicted 
for an assay containing a mixture of both PPl and 
PP2A [l&19]. 
4. DISCUSSION 
This study shows that cantharidin, a natural toxicant 
of several species of blister beetles [ 1,3] is a potent inhib- 
itor of serine/threonine protein phosphatases types 
l(PP1) and 2A (PP2A) and a weak inhibitor of the 
Ca’+/calmodulin-dependent phosphatase, PP2B. Thus, 
cantharidin may be added to a growing list of natural 
toxins that strongly inhibit the activity of both PPl and 
PP2A which include: okadaic acid, a polyether carbox- 
ylic acid produced by several species of marine 
dinoflagelates [24,25]; the microcystins, a family of cy- 
clic heptapeptides produced by certain strains of cyano- 
bacteria [ 19,26,27]; nodularin, a cyclic pentapeptide 
produced by Nodzduriu spumigena [18]; calyculin A, a 
Spiro ketal obtained from a marine sponge [28] and 
-Log [Toxin; (M)] 
Fig. 4. Effect of okadatc acid and canthartdm on protein phosphatase 
activity contamed in a homogenate of PC12 cells. Cells from a single 
-50% cont’ment IOO-mm dish were rinsed with 4°C phosphate-buffered 
saline, scraped and somcated in 1 ml of Trts-buffer (20 mM Tris-HCl. 
1 mM EDTA and 2 mM dithiothreitol. pH 7.4). The homogenate was 
then diluted below the tttration end point (the concentratton after 
u hich further dilution no longer affects the IC,,, [l&19]. -6Opg protein/ 
ml) and assayed for phosphohtstone phosphatase acttvtty as described 
in Fig. 2 Each pomt represents the mean f S D. of three experiments 
conducted in triplicate. 
tautomycin, a dialkylmaleic anhydride produced by a 
strain of Streptonzyces spiroverticillutus [29-311. 
Like okadaic acid and the cyanobacterial toxins (mi- 
corcystins and nodularin), the inhibitory effect of can- 
tharidin differs substantially among the cantharidin- 
sensitive phosphatases. The purified catalytic subunit of 
PP2A from muscle is inhibited by cantharidin at a con- 
centration that is 5-lo-times lower than that required 
to inhibit the activity of purified PPl (Table I, Fig. 2). 
With okadaic acid, PP2A is inhibited at a lo-lOO-fold 
lower concentration than PPl [18,24,25], while both mi- 
crocystin-LR [19,26] and nodularin [18] are 460-fold 
more potent inhibitors of PP2A than PPl. However, 
due the extremely high apparent affinity of microcystin- 
LR and nodularin for both PPl and PP2A, the differ- 
ence in the relative potency of these compounds can 
only be observed in very dilute or high volume assays 
employing radiolabeled substrates with very high spe- 
Table I 
Inhibition of PPl and PP2A by cantharidin 
Inhtbitor Substrate 
PP2A PPl 
K, 01M) 12 K W) II PPllPP2A 
Canthartdin Phosphohistone 0.194 84 1.11 35 5.72 
(0.037) (0.27) 
The dissociation constants (K,) estimated by the dose-inhibition analysis are listed for PPl and PP2A. The K, values are expressed in,uM with 95% 
confidence (in parentheses); n denotes the total number of determinattons utthzed in deriving K, esttmates. and the PPl/PP2A is the ratio of K, values 
for PPl to that for PPZA using phosphohistone as a substrate. 
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cific activity [18,19]. In contrast, calyculin A inhibits the 
activity of both PPI and PPZA at a similar concentra- 
tion [28], and tautomycin, which is a relatively unstable 
compound [31], has been reported to inhibit PPl at a 
slightly lower concentration than PPZA [29,30]. 
Because of the inhibitory effects it has on PPl 
and PP2A, okadaic acid has proven to be a valuable 
research tool for determining the physiological and 
pathological roles of serine/threonine protein 
phosphatases [24,33]. Cantharidin, which is readily 
available and economical, may also be useful as a re- 
search tool. In dilute whole cell homogenates, PPl and 
PP2A make up the majority of the divalent cation inde- 
pendent protein phosphatase activity contained in most 
mammalian tissues [32,33]. Like okadaic acid, can- 
tharidin completely inhibits the divalent cation-inde- 
pendent protein phosphatase activity contained in a 
crude PC12 cell homogenate, with essentially complete 
inhibition occurring at a concentration ~100 ,uM (Fig. 
4). Therefore, cantharidin also appears to be an effec- 
tive inhibitor of the ‘native forms’ of PPl and PP2A. 
Furthermore. like okadaic acid, the dose-inhibition re- 
lationship produced with cantharidin is biphasic, with 
characteristics similar to that predicted from a solution 
containing both PPl and PP2A [18,19]. Nonetheless, 
additional experiments addressing the specificity, stabil- 
ity and metabolism of cantharidin will be required to 
fully assess the value of this toxin as a research tool for 
the detection and analysis of protein phosphatases. 
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